Sign In
Get Clay Free →

Suggestions

    Michael Kokesh

    President & Chief Executive Officer at ViCardia Therapeutics, Inc.

    Michael Kokesh is the President and Chief Executive Officer of ViCardia Therapeutics, Inc..45 He is located in San Francisco, California.145 Kokesh founded ViCardia Therapeutics in 2017, which is a clinical-stage biopharmaceutical company focusing on novel therapies for heart failure related to mitochondrial dysfunction.134 ViCardia is currently entering Phase 2 trials with GP531, an orally active therapy for heart failure.4

    Kokesh has been an executive officer, founder, or co-founder of four successful medical technology and life sciences companies financed by institutional venture capital.123 Prior to his role at ViCardia, he served as the CEO of the Ischemia Research and Education Foundation (IREF), a cardiovascular institute in San Francisco, where he worked with Dr. Herskowitz on the EPI-2 epidemiology study in cardiac bypass surgery.123

    Kokesh holds a B.A./B.S. in Molecular Biology, Political Science, and English Literature from the University of Colorado at Boulder, and a Juris Doctor from the UC – San Francisco.1 He is a member of the California Bar Association and a Fellow of the American Bar Foundation.23 He also holds Series 7 and Series 66 licenses from the Financial Industry Regulatory Authority (FINRA).4 In addition to his role at ViCardia Therapeutics, Inc., Kokesh is also the Managing Director at Ramparts Asset Management Company, LLC.4

    Highlights

    Feb 2 · vicardia.com
    About Us - ViCardia
    Apr 1 · bio.org
    Michael Kokesh, JD - BIO CEO & Investor Conference
    Apr 1 · bio.org
    Michael Kokesh - BIO Investor Forum
    Michael Kokesh - BIO Investor Forum

    Related Questions

    What are Michael Kokesh's key achievements at ViCardia Therapeutics?
    How did Michael Kokesh's experience at the Ischemia Research and Education Foundation influence his leadership at ViCardia?
    What is the significance of GP-531 in ViCardia Therapeutics' pipeline?
    How does Michael Kokesh's diverse educational background impact his approach to leading a biopharmaceutical company?
    What are the main challenges Michael Kokesh has faced as the CEO of ViCardia Therapeutics?
    Michael Kokesh
    Michael Kokesh, photo 1
    Michael Kokesh, photo 2
    Add to my network

    Location

    San Francisco, California, United States